🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Alex Bick, Kun Zhao, and I are excited to share our preprint describing mosaic chromosomal alterations (mCAs) across 1 million people in Vanderbilt BioVU, UK Biobank, NHLBI TOPMed, and NIH All of Us. Co-tweetorial from Kun and me to follow! medrxiv.org/content/10.110… 1/8

#MedicalGrandRounds with QIM Chief Residents, Roslyn Mainland & Anna Tyker. Topics: Micronutrients and Hematology: Sweat the Small Stuff/Refining Skills: The Journey to Endobronchial Ultrasound Bronchoscopy Expertise at KHSC. Thur, Mar. 20 7:45AM. 💻[email protected] to join

#NephMadness 2025: Genetics Region bit.ly/3QFfuJv Teams: - Genetics in FSGS - Genetic Counseling Expert: Jordan Nestor Writer: Matthew Gross Execs: Elena Cervantes & Matthew Sparks, MD

Brigham and Women's Hospital is one of the few centers in the world with a comprehensive Onconephrology practice, led by Drs. Shruti Gupta and Raad Chowdhury, MD, FASN Latest manuscript highlights that experience: bit.ly/4ii94fJ Congrats Oncneph team, you give patients from all over hope!

Our latest review NDT : #CHIP Clonal Hematopoiesis of Indeterminate Potential: A Review of its Cardiorenal Implications and Aging 🐦 Will we ever get to a #CHRP ? More to come.. Abdullah Jalal Kenar Jhaveri American Society of Onconephrology ASH bit.ly/4bJO9zN

The stomach is an organ unique in its function, environment and exposures. How does this affect the mutations that normal cells in the stomach acquire? What does this reveal about the origins of stomach cancer? These questions and more in our Nature paper: nature.com/articles/s4158…

Big day — our JAMA review on ADPKD is out today! 📢 Grateful to the JAMA editorial team for their partnership in shaping this into a high-impact resource for clinicians. If you manage patients with Polycystic Kidney Disease, we hope you’ll find it valuable.

Terrific work from Iftikhar J. Kullo. *10y* fu MI-GENES trial (ahajournals.org/doi/10.1161/CI… Circulation) now shows that CAD PRS disclosure vs not on top of clinical risk disclosure for intermediate risk adults leads to reduction in MACE ahajournals.org/doi/10.1161/CI… Circulation: Genomic and Precision Medicine #ACC25 Small trial

Excited to share our latest review on Clonal Hematopoiesis of Indeterminate Potential (CHIP) and its renal & cardiac implications! #CHIP #Nephrology Check out the tweetorial below! 👇 NDT @bwhkidney Mayo Clinic Nephrology HofNorthwell Kidney Full Manuscript:

11/ ✨Will there be a Clonal Hematopoiesis of Renal Potential #CHRP? 💡More renal mechanistic studies needed 📚 💡strong histopathology link still to be demonstrated 🔗 🎯Need to show change in renal outcomes with targeted interventions #Nephrology #CHRP #RenalResearch #CHIP

Queen’s #NephMadness 2025 bracket submitted! 🫘 🏆

#MedicalGrandRounds VIRTUAL ONLY with QIM Chief Residents, Sarah Hammond & Aaron Rainnie. Topics: Perioperative Management of CKD: Urine Good Hands and Pleural Effusion Characteristics - The Use of Point of Care Ultrasound🗓️Thurs, April 10 7:45AM.💻[email protected] to join.

On the heels of our two collaborative studies connecting clonal hematopoiesis to kidney outcomes (journals.lww.com/jasn/abstract/… & journals.lww.com/jasn/abstract/…), delighted to share our review synthesizing the evidence to-date on clonal hematopoiesis and kidney disease led by Zhi Yu

Growing evidence links clonal hematopoiesis🧬to kidney disease 🫘 Check out a review of recent findings by us Pradeep Natarajan Caitlyn Vlasschaert on JASN_News -including our latest collaborative work on same journal—as we unravel this important connection: journals.lww.com/jasn/abstract/…

Study finds that Non-DNMT3A CHIP was associated with CKD progression among individuals with CKD, and Tet2-CHIP mouse models support a causal role in kidney injury. bit.ly/JASN0680 #ASNJASN

In patients with CKD, non-DNMT3A CHIP was associated with cardiovascular disease with an effect size similar to that reported in the general population. bit.ly/JASN0671 #ASNJASN

Eric Topol NEJM Thanks for being a proponent of CHIP Eric Topol. Our complementary study Cell Reports Medicine: sciencedirect.com/science/articl… Marco Buttigieg Caitlyn Vlasschaert Alex Bick @rob_vanner

Trio of studies, including this, ours & Ross Levine group. Tumor-infiltrating clonal hematopoiesis (TI-CH or CH-Tum) leads to: -worse cancer outcomes -inflammatory TME shaped by CH myeloid cells -potentially targetable changes sciencedirect.com/science/articl… biorxiv.org/content/10.110…

What a great multi-center collaboration by Onconephrology leaders. Can prophylactic IV Mag be beneficial in Cisplatin-Associated AKI? Check out the #tweetorial ! American Society of Onconephrology

Phenomenal paper from Oriol Pich Elsa Bernard out in NEJM exploring tumour-infiltrating clonal hematopoiesis! Many interesting findings complementary to our work in Cell Reports Medicine connecting TI-CH/CH-Tum with worsened clinical outcomes and dysregulated myeloid immunity